Our lead working model postulates that changes in Krt14/Krt15 content alters BC behavior by modifying Sfn abundance, which, in turn, affects signal transduction cascades that balance proliferation and differentiation (i.e., dNp63 nuclear export and proteasomal degradation). Here, KRT15 is linked to breast cancer.